
Improving Cancer Outcomes
Monitoring advances in cancer treatment and research
Life Science Report 2025
properties.trackTitle
properties.trackSubtitle
Although still the leading cause of death among policyholders, cancer is increasingly becoming a manageable disease, reshaping the entire insurance landscape. The rise of personalized medicine and AI-driven diagnostics is revolutionizing how we prevent, detect, and treat cancer. As medical research continues to advance in this field, it is crucial for insurers to closely monitor the implications for insurance products and healthcare costs.
Munich Re's Life Science Report provides a comprehensive guide to assessing both the promises and pitfalls of emerging medical trends and risks, helping life and health insurers to better navigate this environment of changing mortality and morbidity. The report examines the topics of Artificial Intelligence in Healthcare, Improving Cancer Outcomes, Prevention, Obesity and Climate Change.
Improving Cancer Outcomes – Key Facts
Improving Cancer Outcomes
Explore the Life Science Report
Subscribe to newsletter for other topics
Contact our experts
North America
/Gina%20Guzman.jpg/_jcr_content/renditions/original./Gina%20Guzman.jpg)

/Brad%20Heltemes.jpg/_jcr_content/renditions/original./Brad%20Heltemes.jpg)
Europe & Latin America




Asia Pacific, Middle East & Africa

- aarmuss@munichre.com
- vCard
- Download


